Multiple clinical studies have demonstrated that both HIF-1α and HIF-2α are broadly upregulated in the lungs and circulation of PAH patients, primarily originating from pulmonary arterial endothelial cells and smooth muscle cells. This evidence concerns the gene HIF1A and pulmonary arterial hypertension.